» Articles » PMID: 16249934

Effect of Oxygen Limitation on the in Vitro Antimicrobial Susceptibility of Clinical Isolates of Pseudomonas Aeruginosa Grown Planktonically and As Biofilms

Overview
Publisher Springer
Date 2005 Oct 27
PMID 16249934
Citations 28
Authors
Affiliations
Soon will be listed here.
Abstract

Pseudomonas aeruginosa, the predominant causative pathogen of chronic lung infection in patients with cystic fibrosis, may grow under anaerobic conditions as biofilms in the lungs of cystic fibrosis patients. To determine if growth under anaerobic conditions affects the antimicrobial susceptibility of P. aeruginosa, the susceptibility of clinical isolates of P. aeruginosa grown planktonically and as biofilms to a range of antibiotics was determined. Growth under anaerobic conditions did not reduce the ability of ceftazidime, meropenem, aztreonam, piperacillin, or piperacillin/tazobactam to inhibit planktonic growth, with MIC50 values for these antibiotics remaining unchanged or decreasing. However, tobramycin was less effective at inhibiting planktonic bacterial growth under anaerobic conditions, with the MIC50 of tobramycin increasing twofold. Growth under anaerobic conditions also decreased the bactericidal activity of tobramycin, with the MBC50 of tobramycin increasing fourfold. The killing kinetics of tobramycin was also examined under aerobic and anaerobic conditions for selected isolates. When isolates 6A and 12A were grown aerobically, concentration-dependent decreases in total viable count were apparent with tobramycin. In contrast, when these isolates were grown anaerobically, tobramycin at the same concentrations did not decrease the total viable count. When isolates were grown as biofilms under both aerobic and anaerobic conditions, isolate- and concentration-dependent differences in killing of the biofilms by tobramycin were apparent. However, tobramycin at concentrations up to 128 mg/l was unable to eradicate biofilms of any of the isolates tested, whether biofilms were grown aerobically or anaerobically. These results show that oxygen limitation may reduce, in a strain-dependent manner, the susceptibility to tobramycin of P. aeruginosa grown planktonically and as biofilms.

Citing Articles

Investigating the Potential of L(+)-Lactic Acid as a Green Inhibitor and Eradicator of a Dual-Species spp. Biofilm Formed on Food Processing Model Surfaces.

Kostoglou D, Apostolopoulou M, Lagou A, Didos S, Argiriou A, Giaouris E Microorganisms. 2024; 12(11).

PMID: 39597514 PMC: 11596057. DOI: 10.3390/microorganisms12112124.


Pseudomonas aeruginosa is oxygen-deprived during infection in cystic fibrosis lungs, reducing the effectiveness of antibiotics.

Martin L, Gray A, Brockway B, Lamont I FEMS Microbiol Lett. 2023; 370.

PMID: 37516450 PMC: 10408701. DOI: 10.1093/femsle/fnad076.


Determining effects of nitrate, arginine, and ferrous on antibiotic recalcitrance of clinical strains of Pseudomonas aeruginosa in biofilm-inspired alginate encapsulates.

Jabalameli F, Emaneini M, Beigverdi R, Halimi S, Siroosi M Ann Clin Microbiol Antimicrob. 2023; 22(1):61.

PMID: 37475017 PMC: 10360276. DOI: 10.1186/s12941-023-00613-y.


Niche, not phylogeny, governs the response to oxygen availability among diverse strains.

Shewaramani S, Kassen R Front Microbiol. 2022; 13:953964.

PMID: 36060748 PMC: 9428489. DOI: 10.3389/fmicb.2022.953964.


Strategies to Improve the Potency of Oxazolidinones towards Bacterial Biofilms.

Ndukwe A, Wiedbrauk S, Boase N, Fairfull-Smith K Chem Asian J. 2022; 17(11):e202200201.

PMID: 35352479 PMC: 9321984. DOI: 10.1002/asia.202200201.


References
1.
Hassett D, Cuppoletti J, Trapnell B, Lymar S, Rowe J, Yoon S . Anaerobic metabolism and quorum sensing by Pseudomonas aeruginosa biofilms in chronically infected cystic fibrosis airways: rethinking antibiotic treatment strategies and drug targets. Adv Drug Deliv Rev. 2002; 54(11):1425-43. DOI: 10.1016/s0169-409x(02)00152-7. View

2.
Sias S, Stouthamer A, Ingraham J . The assimilatory and dissimilatory nitrate reductases of Pseudomonas aeruginosa are encoded by different genes. J Gen Microbiol. 1980; 118(1):229-34. DOI: 10.1099/00221287-118-1-229. View

3.
Davey P, Barza M, Stuart M . Tolerance of Pseudomonas aeruginosa to killing by ciprofloxacin, gentamicin and imipenem in vitro and in vivo. J Antimicrob Chemother. 1988; 21(4):395-404. DOI: 10.1093/jac/21.4.395. View

4.
Costerton J, Stewart P, Greenberg E . Bacterial biofilms: a common cause of persistent infections. Science. 1999; 284(5418):1318-22. DOI: 10.1126/science.284.5418.1318. View

5.
Aaron S, Ferris W, Henry D, Speert D, MacDonald N . Multiple combination bactericidal antibiotic testing for patients with cystic fibrosis infected with Burkholderia cepacia. Am J Respir Crit Care Med. 2000; 161(4 Pt 1):1206-12. DOI: 10.1164/ajrccm.161.4.9907147. View